Reliability of leptin, but not adiponectin, as a biomarker for diet-induced weight loss in humans

Nutrition Reviews

Volumn 69, Issue 3, 2011, Pages 145-154

  Klempel, Monica C ^a   Varady, Krista A ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

Adipokines; Calorie restriction; Obesity; Visceral fat; Weight loss

Indexed keywords

ADIPONECTIN; INTERLEUKIN 6; INTERLEUKIN 8; LEPTIN; MONOCYTE CHEMOTACTIC PROTEIN 1; RESISTIN; RETINOL BINDING PROTEIN 4;

ARTICLE; BLOOD LEVEL; CALORIC RESTRICTION; DISEASE ASSOCIATION; HORMONE BLOOD LEVEL; HUMAN; INTRAABDOMINAL FAT; OBESITY; PROTEIN BLOOD LEVEL; WEIGHT REDUCTION;

ADIPONECTIN; BIOLOGICAL MARKERS; CALORIC RESTRICTION; HUMANS; LEPTIN; OBESITY; WEIGHT LOSS;

EID: 79951933015     PISSN: 00296643     EISSN: 17534887     Source Type: Journal    
DOI: 10.1111/j.1753-4887.2011.00373.x     Document Type: Article

References (65)

1. Poirier P, Giles TD, Bray GA, etal. Obesity and cardiovascular disease: pathophysiology, evaluation, and effect of weight loss: an update of the 1997 American Heart Association Scientific Statement on Obesity and Heart Disease from the Obesity Committee of the Council on Nutrition, Physical Activity, and Metabolism. Circulation. 2006;113:898-918.
2. Fontana L. Calorie restriction and cardiometabolic health. Eur J Cardiovasc Prev Rehabil. 2008;15:3-9.
3. Ross R, Bradshaw AJ. The future of obesity reduction: beyond weight loss. Nat Rev Endocrinol. 2009;5:319-325.
4. Fantuzzi G, Mazzone T. Adipose tissue and atherosclerosis: exploring the connection. Arterioscler Thromb Vasc Biol. 2007;27:996-1003.
5. Gnacinska M, Malgorzewicz S, Stojek M, Lysiak-Szydlowska W, Sworczak K. Role of adipokines in complications related to obesity: a review. Adv Med Sci. 2009;54:150-157.
6. Ziemke F, Mantzoros CS. Adiponectin in insulin resistance: lessons from translational research. Am J Clin Nutr. 2010;91:S258-S261.
7. de Luis DA, Perez Castrillon JL, Duenas A. Leptin and obesity. Minerva Med. 2009;100:229-236.
8. Nogueiras R, Novelle MG, Vazquez MJ, Lopez M, Dieguez C. Resistin: regulation of food intake, glucose homeostasis and lipid metabolism. Endocr Dev. 2010;17:175-184.
9. O'Keefe JH, Gheewala NM, O'Keefe JO. Dietary strategies for improving post-prandial glucose, lipids, inflammation, and cardiovascular health. J Am Coll Cardiol. 2008;51:249-255.
10. Varady KA, Hellerstein MK. Do calorie restriction or alternate-day fasting regimens modulate adipose tissue physiology in a way that reduces chronic disease risk? Nutr Rev. 2008;66:333-342.
11. Wiecek A, Adamczak M, Chudek J. Adiponectin - an adipokine with unique metabolic properties. Nephrol Dial Transplant. 2007;22:981-988.
12. Ouchi N, Kihara S, Arita Y, etal. Novel modulator for endothelial adhesion molecules: adipocyte-derived plasma protein adiponectin. Circulation. 1999;100:2473-2476.
13. Ouchi N, Kihara S, Arita Y, etal. Adipocyte-derived plasma protein, adiponectin, suppresses lipid accumulation and class A scavenger receptor expression in human monocyte-derived macrophages. Circulation. 2001;103:1057-1063.
14. Arita Y, Kihara S, Ouchi N, etal. Adipocyte-derived plasma protein adiponectin acts as a platelet-derived growth factor-BB-binding protein and regulates growth factor-induced common postreceptor signal in vascular smooth muscle cell. Circulation. 2002;105:2893-2898.
15. Yamauchi T, Kamon J, Waki H, etal. The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat Med. 2001;7:941-946.
16. Tajtakova M, Petrasova D, Petrovicova J, Pytliak M, Semanova Z. Adiponectin as a biomarker of clinical manifestation of metabolic syndrome. Endocr Regul. 2006;40:15-19.
17. Heinonen MV, Laaksonen DE, Karhu T, etal. Effect of diet-induced weight loss on plasma apelin and cytokine levels in individuals with the metabolic syndrome. Nutr Metab Cardiovasc Dis. 2009;19:626-633.
18. Esposito K, Pontillo A, Di Palo C, etal. Effect of weight loss and lifestyle changes on vascular inflammatory markers in obese women: a randomized trial. JAMA. 2003;289:1799-1804.
19. Belza A, Toubro S, Stender S, Astrup A. Effect of diet-induced energy deficit and body fat reduction on high-sensitive CRP and other inflammatory markers in obese subjects. Int J Obes (Lond). 2009;33:456-464.
20. Chan DC, Watts GF, Ng TW, Yamashita S, Barrett PH. Effect of weight loss on markers of triglyceride-rich lipoprotein metabolism in the metabolic syndrome. Eur J Clin Invest. 2008;38:743-751.
21. Larrouy D, Barbe P, Valle C, etal. Gene expression profiling of human skeletal muscle in response to stabilized weight loss. Am J Clin Nutr. 2008;88:125-132.
22. Claessens M, van Baak MA, Monsheimer S, Saris WH. The effect of a low-fat, high-protein or high-carbohydrate ad libitum diet on weight loss maintenance and metabolic risk factors. Int J Obes (Lond). 2009;33:296-304.
23. Christiansen T, Paulsen SK, Bruun JM, Pedersen SB, Richelsen B. Exercise training versus diet-induced weight-loss on metabolic risk factors and inflammatory markers in obese subjects: a 12-week randomized intervention study. Am J Physiol Endocrinol Metab. 2010;298:E824-E831.
24. Keogh JB, Brinkworth GD, Clifton PM. Effects of weight loss on a low-carbohydrate diet on flow-mediated dilatation, adhesion molecules and adiponectin. Br J Nutr. 2007;98:852-859.
25. Mahon AK, Flynn MG, Stewart LK, etal. Protein intake during energy restriction: effects on body composition and markers of metabolic and cardiovascular health in postmenopausal women. J Am Coll Nutr. 2007;26:182-189.
26. Arvidsson E, Viguerie N, Andersson I, Verdich C, Langin D, Arner P. Effects of different hypocaloric diets on protein secretion from adipose tissue of obese women. Diabetes. 2004;53:1966-1971.
27. Garaulet M, Viguerie N, Porubsky S, etal. Adiponectin gene expression and plasma values in obese women during very-low-calorie diet. Relationship with cardiovascular risk factors and insulin resistance. J Clin Endocrinol Metab. 2004;89:756-760.
28. Koh SJ, Hyun YJ, Choi SY, etal. Influence of age and visceral fat area on plasma adiponectin concentrations in women with normal glucose tolerance. Clin Chim Acta. 2008;389:45-50.
29. Kratz M, Swarbrick MM, Callahan HS, Matthys CC, Havel PJ, Weigle DS. Effect of dietary n-3 polyunsaturated fatty acids on plasma total and high-molecular-weight adiponectin concentrations in overweight to moderately obese men and women. Am J Clin Nutr. 2008;87:347-353.
30. de Luis DA, Aller R, Izaola O, Gonzalez Sagrado M, Bellioo D, Conde R. Effects of a low-fat versus a low-carbohydrate diet on adipocytokines in obese adults. Horm Res. 2007;67:296-300.
31. Kabrnova-Hlavata K, Hainer V, Gojova M, etal. Calcium intake and the outcome of short-term weight management. Physiol Res. 2008;57:237-245.
32. Hochberg I, Hochberg Z. Expanding the definition of hypothalamic obesity. Obes Rev. 2010;11:709-721.
33. de Krom M, van der Schouw YT, Hendriks J, etal. Common genetic variations in CCK, leptin, and leptin receptor genes are associated with specific human eating patterns. Diabetes. 2007;56:276-280.
34. Munzberg H. Leptin-signaling pathways and leptin resistance. Forum Nutr. 2010;63:123-132.
35. Huang F, Xiong X, Wang H, You S, Zeng H. Leptin-induced vascular smooth muscle cell proliferation via regulating cell cycle, activating ERK1/2 and NF-kappaB. Acta Biochim Biophys Sin (Shanghai). 2010;42:325-331.
36. Oswal A, Yeo G. Leptin and the control of body weight: a review of its diverse central targets, signaling mechanisms, and role in the pathogenesis of obesity. Obesity (Silver Spring). 2010;18:221-229.
37. Staiger H, Tschritter O, Machann J, etal. Relationship of serum adiponectin and leptin concentrations with body fat distribution in humans. Obes Res. 2003;11:368-372.
38. Kok P, Roelfsema F, Langendonk JG, etal. High circulating thyrotropin levels in obese women are reduced after body weight loss induced by caloric restriction. J Clin Endocrinol Metab. 2005;90:4659-4663.
39. Torgerson JS, Carlsson B, Stenlof K, Carlsson LM, Bringman E, Sjostrom L. A low serum leptin level at baseline and a large early decline in leptin predict a large 1-year weight reduction in energy-restricted obese humans. J Clin Endocrinol Metab. 1999;84:4197-4203.
40. Lofgren P, Andersson I, Adolfsson B, etal. Long-term prospective and controlled studies demonstrate adipose tissue hypercellularity and relative leptin deficiency in the postobese state. J Clin Endocrinol Metab. 2005;90:6207-6213.
41. Mitterberger MC, Mattesich M, Klaver E, etal. Adipokine profile and insulin sensitivity in formerly obese women subjected to bariatric surgery or diet-induced long-term caloric restriction. J Gerontol A Biol Sci Med Sci. 2010;65:915-923.
42. Polito A, Fabbri A, Ferro-Luzzi A, etal. Basal metabolic rate in anorexia nervosa: relation to body composition and leptin concentrations. Am J Clin Nutr. 2000;71:1495-1502.
43. Capel F, Viguerie N, Vega N, etal. Contribution of energy restriction and macronutrient composition to changes in adipose tissue gene expression during dietary weight-loss programs in obese women. J Clin Endocrinol Metab. 2008;93:4315-4322.
44. Kovacikova M, Vitkova M, Klimcakova E, etal. Visfatin expression in subcutaneous adipose tissue of pre-menopausal women: relation to hormones and weight reduction. Eur J Clin Invest. 2008;38:516-522.
45. Ramel A, Parra D, Martinez JA, Kiely M, Thorsdottir I. Effects of seafood consumption and weight loss on fasting leptin and ghrelin concentrations in overweight and obese European young adults. Eur J Nutr. 2009;48:107-114.
46. Yang RZ, Huang Q, Xu A, etal. Comparative studies of resistin expression and phylogenomics in human and mouse. Biochem Biophys Res Commun. 2003;310:927-935.
47. Barnes KM, Miner JL. Role of resistin in insulin sensitivity in rodents and humans. Curr Protein Pept Sci. 2009;10:96-107.
48. Li FP, He J, Li ZZ, Luo ZF, Yan L, Li Y. Effects of resistin expression on glucose metabolism and hepatic insulin resistance. Endocrine. 2009;35:243-251.
49. Tilg H, Moschen AR. Adipocytokines: mediators linking adipose tissue, inflammation and immunity. Nat Rev Immunol. 2006;6:772-783.
50. Bokarewa M, Nagaev I, Dahlberg L, Smith U, Tarkowski A. Resistin, an adipokine with potent proinflammatory properties. J Immunol. 2005;174:5789-5795.
51. Fain JN. Release of inflammatory mediators by human adipose tissue is enhanced in obesity and primarily by the nonfat cells: a review. Mediators Inflamm. 2010;2010:513948.
52. Galic S, Oakhill JS, Steinberg GR. Adipose tissue as an endocrine organ. Mol Cell Endocrinol. 2010;316:129-139.
53. Browning LM, Krebs JD, Magee EC, Fruhbeck G, Jebb SA. Circulating markers of inflammation and their link to indices of adiposity. Obes Facts. 2008;1:259-265.
54. Peairs AT, Rankin JW. Inflammatory response to a high-fat, low-carbohydrate weight loss diet: effect of antioxidants. Obesity (Silver Spring). 2008;16:1573-1578.
55. Gerhardt CC, Romero IA, Cancello R, Camoin L, Strosberg AD. Chemokines control fat accumulation and leptin secretion by cultured human adipocytes. Mol Cell Endocrinol. 2001;175:81-92.
56. Van Gaal LF, Mertens IL, De Block CE. Mechanisms linking obesity with cardiovascular disease. Nature. 2006;444:875-880.
57. Kim CS, Park HS, Kawada T, etal. Circulating levels of MCP-1 and IL-8 are elevated in human obese subjects and associated with obesity-related parameters. Int J Obes (Lond). 2006;30:1347-1355.
58. Plat J, Jellema A, Ramakers J, Mensink RP. Weight loss, but not fish oil consumption, improves fasting and postprandial serum lipids, markers of endothelial function, and inflammatory signatures in moderately obese men. J Nutr. 2007;137:2635-2640.
59. Tamori Y, Sakaue H, Kasuga M. RBP4, an unexpected adipokine. Nat Med. 2006;12:30-31.
60. Yang Q, Graham TE, Mody N, etal. Serum retinol binding protein 4 contributes to insulin resistance in obesity and type 2 diabetes. Nature. 2005;436:356-362.
61. Graham TE, Yang Q, Bluher M, etal. Retinol-binding protein 4 and insulin resistance in lean, obese, and diabetic subjects. N Engl J Med. 2006;354:2552-2563.
62. Vitkova M, Klimcakova E, Kovacikova M, etal. Plasma levels and adipose tissue messenger ribonucleic acid expression of retinol-binding protein 4 are reduced during calorie restriction in obese subjects but are not related to diet-induced changes in insulin sensitivity. J Clin Endocrinol Metab. 2007;92:2330-2335.
63. Butner KL, Nickols-Richardson SM, Clark SF, Ramp WK, Herbert WG. A review of weight loss following Roux-en-Y gastric bypass versus restrictive bariatric surgery: impact on adiponectin and insulin. Obes Surg. 2010;20:559-568.
64. Beckman LM, Beckman TR, Earthman CP. Changes in gastrointestinal hormones and leptin after Roux-en-Y gastric bypass procedure: a review. J Am Diet Assoc. 2010;110:571-584.
65. Gumbs AA, Modlin IM, Ballantyne GH. Changes in insulin resistance following bariatric surgery: role of caloric restriction and weight loss. Obes Surg. 2005;15:462-473.